2012 AUA Foundation Basic Science Symposium
"Nanomedicine: Applications in Urology Today"
Friday, May 18th, 1:30 p.m.-7:00 p.m.
Georgia World Congress Center, Rooms A-404/405
Understanding how to harness the power and innovation inherent in the field of nanotechnology has the potential to revolutionize patient care across the spectrum of urologic diseases including development of approaches to drug delivery, improvement of drug bioavailability, and use of nanoparticles in oncology, particularly in imaging and nanonephrology. The program provides an overview of the field to describe the current state of research via keynote talks from leaders in the field, integrates and discusses the application of the topic to urology research, and explores the translational aspects of the topic.
The goals of this conference are to advance progress in urology, recruit and stimulate the interest of individuals engaged in or having an interest in traditional and non-traditional urologic research, and to build bridges among basic scientists, academic urologists active in research and clinical urologists interested in research. The conference will focus on an overarching basic science theme of broad appeal to attract a multidisciplinary audience. Juxtaposing the conference to the beginning of the AUA National meeting will increase basic science presence at the Annual Meeting and should further attract interest from the urology community. The support of young investigators to attend the conference will be primarily focused on individuals who would not normally attend the AUA National meeting although all young investigators will be encouraged to attend and will be supported as possible.
The Program Chairs are Robert Getzenberg, PhD, Research Director of Johns Hopkins Medical Institutions, and Piotr Grodzinski, PhD, Director of the National Cancer Institute Office of Cancer Nanotechnology Research. The program speakers are Edward Garmey, MD (Cerulean Pharma, Inc.); Alexis Te, MD (Weill Cornell); Richard Lee, MD (Weill Cornell); Martin Pomper, MD (Johns Hopkins); Stephen Curley, MD (MD Anderson); and Dong Shin, MD (Emory).
View the Program Agenda.
